People with haemophilia, their families, and their doctors feel threatened by the deluge of speculation about the possible side effects of treatment with blood products. Two topics hold their attention: the risk of contracting the acquired immunodeficiency syndrome (AIDS) and the risk of developing hepatitis and subsequent chronic liver disease.
Centers for Disease Control in Atlanta define a case of AIDS as "a reliably diagnosed disease that is at least moderately indicative of an underlying cellular immunodeficiency in a person who has had no known underlying cause of cellular immunodeficiency and no other cause of reduced resistance reported to be associated with that disease."' For epidemiological purposes this definition is wide; it does not suggest a single aetiological agent, merely a similar response, or lack of it, to injury. It is important to recognise this in view of the difficulty in classifying the different disorders concerned and the current reaction of the media to announcements of "new" cases. Until diagnostic markers for the disorder are found terms like "confirmed AIDS 
